Bioprogress Future2

Some interesting/valuable old discussion surrounding ostomy/Convatec/Ecoprogress (and other things we know a very little more about now, at least broad brush).



Those were understandings and expectations then; what are they now? What has held Convatec up? For a while, some thought it was a refined flange requirement. I wonder if it might be something entirely different.

Any connection between these things? Or is my imagination running wild again? Enitrely possible.


CONSOLIDATED ECOPROGRESS TECHNOLOGY INC. ("CES")
BULLETIN TYPE: Resume Trading
BULLETIN DATE: July 19, 2005
TSX Venture Tier 2 Company

Effective at the opening, PST, July 19, 2005, shares of the Company resumed trading, an announcement having been made over StockWatch.

-plus-

BioProgress PLC announces Issue of Equity
Cambridgeshire -- (MARKET WIRE) -- 07/27/2005 --

BioProgress plc

("BioProgress" or "the Company")

Issue of Equity

BioProgress plc (AIM: BPRG; NASDAQ: BPRG), the provider of innovative delivery mechanisms for the pharmaceutical oral dosage markets, announces that as part of a settlement of the claim brought by Mr Charles Tatnall against the Company or its operations, as referred to in the AGM statement on 22 June 2005, 992,908 ordinary shares of 1p each have been issued to Mr Tatnall. Application will be made for these 992,908 ordinary shares of 1p each being admitted to trading on AIM. Admission of these new ordinary shares is expected to be effective on 28 July 2005."